Appointment

Date: 21 September 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai – 400001 Bandra (E) Mumbai – 400051 Security Code: 540596 Symbol: ERIS SUBJECT: APPOINTMENT OF MR. AKHIL AWASTHI AS AN ADDITIONAL DIRECTOR (NON- EXECUTIVE, INDEPENDENT) OF THE COMPANY Pursuant to Regulation 30, read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the ‘SEBI Listing Regulations’), we wish to inform you that the Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, vide their Circular Resolution dated September 21, 2026, has approved the appointment of Mr. Akhil Awasthi (DIN: 00148350) as an Additional Director (Non-executive, Independent) of the Company for a term of five years, effective from September 26, 2026, subject to the approval of the members. Details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Master circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026 is enclosed as Annexure. Kindly take the above information on record. Thanking You, For Eris Lifesciences Limited Milind Talegaonkar Company Secretary & Compliance Officer Membership No: A26493 Annexure Sr. No. Particulars Details 1. Reason for Change viz. appointment, re- Appointed as an Additional Director (Non-executive, appointment, resignation, removal, death or Independent) of the Company otherwise; 2. Date of appointment / reappointment / September 26, 2026 cessation (as applicable) & term of appointment/re-appointment Appointed as an Additional Director (Non-executive, Independent) of the Company for a term of 5 years. 3. brief profile (in case of appointment) Mr. Akhil Awasthi is a seasoned investment professional with over three decades of experience in private equity, investment management, healthcare and lifesciences, business transformation and corporate governance. He has held senior positions, including Founding Managing Partner and Investment Committee Member of Tata Capital Growth Fund and Partner at Baring Private Equity Partners (India) Ltd., with significant experience in investments, strategic value creation and board-level governance. 4. Disclosure of relationships between Mr. Akhil Awasthi is not related to any Director of directors (in case of appointment of a the Company. director) 5. Information as required pursuant to BSE Mr. Akhil Awasthi is not debarred from holding the circular ref no. LIST/ COMP/ 14/ 2018-19 office of Director by virtue of any SEBI or any other and the National Stock Exchange of India such authority. Limited with ref no. NSE/CML/2018/24, dated June 20, 2018